NextPlat (NASDAQ:NXPL) Shares Down 6% – What’s Next?

NextPlat Corp. (NASDAQ:NXPL) fell 6% during trading on Monday . The company traded as low as $0.4870 and last traded at $0.4910. 31,745 shares traded hands during trading, a decline of 31% from the average session volume of 46,277 shares. The stock had previously closed at $0.5221.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

NextPlat Trading Down 6.0%

The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56. The stock has a market capitalization of $12.92 million, a P/E ratio of -1.64 and a beta of 1.23. The stock has a 50-day moving average price of $0.62 and a two-hundred day moving average price of $0.70.

Institutional Investors Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Simplicity Wealth LLC bought a new stake in shares of NextPlat Corp. (NASDAQ:NXPL) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned approximately 2.31% of NextPlat at the end of the most recent quarter. Hedge funds and other institutional investors own 1.30% of the company’s stock.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.